RNMBF(RNMBF)
RNMBF
No analyst ratings available
No analyst price targets available for RNMBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $14.12B | $19.02B | $25.12B | $33.11B | $42.42B |
| Low | $13.80B | $17.34B | $23.60B | $31.12B | $39.87B |
| High | $14.66B | $20.30B | $26.50B | $34.93B | $44.76B |
| EBITDA Avg | $2.40B | $3.23B | $4.27B | $5.63B | $7.21B |
| Low | $2.35B | $2.95B | $4.01B | $5.29B | $6.78B |
| High | $2.49B | $3.45B | $4.51B | $5.94B | $7.61B |
| EBIT Avg | $1.82B | $2.46B | $3.25B | $4.28B | $5.48B |
| Low | $1.78B | $2.24B | $3.05B | $4.02B | $5.15B |
| High | $1.89B | $2.62B | $3.42B | $4.51B | $5.78B |
| Net Income Avg | $1.16B | $1.69B | $2.34B | $3.02B | $3.92B |
| Low | $1.07B | $1.56B | $2.15B | $2.78B | $3.61B |
| High | $1.24B | $1.81B | $2.50B | $3.24B | $4.20B |
| EPS Avg | $37.82 | $55.17 | $76.34 | $98.63 | $127.96 |
| Low | $34.86 | $50.85 | $70.36 | $90.90 | $117.94 |
| High | $40.53 | $59.12 | $81.80 | $105.68 | $137.11 |
| Analysts (Rev / EPS) | 20 / 1 | 19 / 1 | 8 / 1 | 9 / 1 | 15 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $3.19B | $5.63B |
| Low | $3.17B | $5.56B |
| High | $3.21B | $5.70B |
| EBITDA Avg | $543M | $957M |
| Low | $539M | $945M |
| High | $547M | $970M |
| EBIT Avg | $412M | $727M |
| Low | $409M | $718M |
| High | $415M | $737M |
| Net Income Avg | $325M | $1.04B |
| Low | $321M | $1.03B |
| High | $330M | $1.06B |
| EPS Avg | $6.98 | $22.32 |
| Low | $6.88 | $22.01 |
| High | $7.08 | $22.64 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |